438 related articles for article (PubMed ID: 27813124)
1. Noninvasive markers for staging fibrosis in chronic delta hepatitis.
Takyar V; Surana P; Kleiner DE; Wilkins K; Hoofnagle JH; Liang TJ; Heller T; Koh C
Aliment Pharmacol Ther; 2017 Jan; 45(1):127-138. PubMed ID: 27813124
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive Models for Predicting Liver Fibrosis in Individuals with Hepatitis D Virus/Hepatitis B Virus Coinfection in the Brazilian Amazon Region.
Alves Vasconcelos MP; DallÁcqua DV; Wedemeyer H; Witkin SS; Mendes-Corrêa MC; Villalobos-Salcedo JM
Am J Trop Med Hyg; 2020 Jul; 103(1):169-174. PubMed ID: 32431268
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta.
Kalkan Ç; Yılmaz Y; Erdoğan BD; Savaş B; Yurdcu E; Çalışkan A; Keskin O; Gencdal G; Zeybel M; Törüner M; Bozdayi AM; Idilman R; Yurdaydin C
J Viral Hepat; 2023 May; 30(5):406-416. PubMed ID: 36651603
[TBL] [Abstract][Full Text] [Related]
4. Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B.
Sanai FM; Farah T; Albeladi K; Batwa F; Dahlan Y; Babatin MA; Al-Ashgar H; AlMana H; Alsaad KS; AlSwat K; Aljumah A; AlTraif IH; Kailani BE; Bzeizi KI
BMC Gastroenterol; 2017 Aug; 17(1):101. PubMed ID: 28841822
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
[TBL] [Abstract][Full Text] [Related]
7. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
Eminler AT; Ayyildiz T; Irak K; Kiyici M; Gurel S; Dolar E; Gulten M; Nak SG
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
[TBL] [Abstract][Full Text] [Related]
8. The Delta-4 fibrosis score (D4FS): A novel fibrosis score in chronic hepatitis D.
Da BL; Surana P; Kleiner DE; Heller T; Koh C
Antiviral Res; 2020 Feb; 174():104691. PubMed ID: 31837393
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
[TBL] [Abstract][Full Text] [Related]
10. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
[TBL] [Abstract][Full Text] [Related]
11. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
[TBL] [Abstract][Full Text] [Related]
13. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
[TBL] [Abstract][Full Text] [Related]
14. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.
Amorim TG; Staub GJ; Lazzarotto C; Silva AP; Manes J; Ferronato Mda G; Shiozawa MB; Narciso-Schiavon JL; Dantas-Correa EB; Schiavon Lde L
Ann Hepatol; 2012; 11(6):855-61. PubMed ID: 23109448
[TBL] [Abstract][Full Text] [Related]
15. Vibration-controlled transient elastography for the detection of cirrhosis in chronic hepatitis D infection.
Da BL; Surana P; Takyar V; Kleiner DE; Heller T; Koh C
J Viral Hepat; 2020 Apr; 27(4):428-436. PubMed ID: 31742822
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
Tan YW; Zhou XB; Ye Y; He C; Ge GH
World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
[TBL] [Abstract][Full Text] [Related]
17. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.
Lin CL; Liu CH; Wang CC; Liang CC; Su TH; Liu CJ; Kao JH
J Clin Gastroenterol; 2015 Sep; 49(8):705-13. PubMed ID: 25319739
[TBL] [Abstract][Full Text] [Related]
18. Shear wave elastography: How well does it perform in chronic hepatitis D virus infection?
Yang AH; Yardeni D; Hercun J; Kleiner DE; Ling A; Marko J; Heller T; Koh C
J Viral Hepat; 2022 Dec; 29(12):1127-1133. PubMed ID: 36062402
[TBL] [Abstract][Full Text] [Related]
19. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
[TBL] [Abstract][Full Text] [Related]
20. Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis.
Afify SM; Tabll A; Nawara HM; El Kassas M; Elfert A; Seno M; El-Kousy S
Clin Lab; 2018 Oct; 64(10):1685-1693. PubMed ID: 30336529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
